- The folks at Fundaci¢n P£blica Andaluza para la gesti¢n de la Investigaci¢n en Sevilla are studying the effects of Cotrimoxazole; Placebo on Idiopathic Pulmonary Fibrosis in individuals ages 18 years to 80 years. This clinical trial is slated to start June 2013 and is expected to end circa December 2014.Francisco J. Medrano Ortega, PhD
|Recruiting||Francisco J. Medrano Ortega, PhDemail@example.com|
This study is officially titled, "Pilot Study Phase III to Evaluate the Efficacy and Safety of Trimethoprim-sulfamethoxazole in the Treatment of Idiopathic Pulmonary Fibrosis."
|Recruiting||Hospital Universitario Virgen del Roc¡o/ Instituto de Biomedicina de Sevilla|
Spain - map
For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.